JP2002536365A - 貧血と闘うのに使用される置換ピラゾールカルボン酸 - Google Patents

貧血と闘うのに使用される置換ピラゾールカルボン酸

Info

Publication number
JP2002536365A
JP2002536365A JP2000597278A JP2000597278A JP2002536365A JP 2002536365 A JP2002536365 A JP 2002536365A JP 2000597278 A JP2000597278 A JP 2000597278A JP 2000597278 A JP2000597278 A JP 2000597278A JP 2002536365 A JP2002536365 A JP 2002536365A
Authority
JP
Japan
Prior art keywords
anemia
general formula
trifluoromethyl
substituted
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000597278A
Other languages
English (en)
Japanese (ja)
Inventor
シユトルテフス，ユルゲン
ブロインリヒ，ガブリーレ
ヒンツエン，ベルトホルト
クレマー，トマス
ペルネルストルフアー，ヨゼフ
シユトウデマン，トマス
ニールシユ，ウルリヒ
ベヘム，マルテイン
ローアマン，エマニユエル
ゲルデス，クリストフ
シユペルツエル，ミヒヤエル
ルステイヒ，クレメンス
マイア，ロレンツ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JP2002536365A publication Critical patent/JP2002536365A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2000597278A 1999-02-04 2000-01-24 貧血と闘うのに使用される置換ピラゾールカルボン酸 Pending JP2002536365A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19904406A DE19904406A1 (de) 1999-02-04 1999-02-04 Substituierte Pyrazolcarbonsäuren
DE19904406.6 1999-02-04
PCT/EP2000/000511 WO2000046208A1 (de) 1999-02-04 2000-01-24 Substituierte pyrazolcarbonsäuren zur bekämpfung von anämien

Publications (1)

Publication Number Publication Date
JP2002536365A true JP2002536365A (ja) 2002-10-29

Family

ID=7896345

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000597278A Pending JP2002536365A (ja) 1999-02-04 2000-01-24 貧血と闘うのに使用される置換ピラゾールカルボン酸

Country Status (7)

Country Link
EP (1) EP1150958A1 (de)
JP (1) JP2002536365A (de)
AU (1) AU3276600A (de)
CA (1) CA2361816A1 (de)
DE (1) DE19904406A1 (de)
GT (1) GT200000007A (de)
WO (1) WO2000046208A1 (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007043400A1 (ja) * 2005-10-07 2007-04-19 Kissei Pharmaceutical Co., Ltd. 含窒素芳香族複素環化合物およびそれを含有する医薬組成物
JP2008515985A (ja) * 2004-10-13 2008-05-15 ピーティーシー セラピューティクス，インコーポレーテッド ナンセンス抑制の化合物とその使用方法
WO2009041072A1 (ja) 2007-09-27 2009-04-02 Kowa Company, Ltd. テトラヒドロキノリン化合物を有効成分とする貧血の予防及び／又は治療剤
US8435999B2 (en) 2007-08-13 2013-05-07 Monsanto Technology Llc Compositions and methods for controlling nematodes

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19904397A1 (de) * 1999-02-04 2000-08-10 Bayer Ag Verwendung von Pyrazol-Carbonsäureamiden
EP2243777A1 (de) * 2009-04-03 2010-10-27 Bayer CropScience AG Verfahren zum Herstellen von Pyridyl-substituierten Pyrazolen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071834A (en) * 1988-09-16 1991-12-10 Genentech, Inc. Purified activin B composition
JP3269084B2 (ja) * 1992-06-10 2002-03-25 藤沢薬品工業株式会社 貧血治療のためのピラゾロピリジン化合物
EP1510524A3 (de) * 1995-06-07 2006-06-07 Ortho Pharmaceutical Corporation An den Erythropoietin-Rezeptor bindende Zusammensetzungen und Peptide
WO1997019039A1 (en) * 1995-11-17 1997-05-29 Novartis Ag Solid phase synthesis of heterocyclic compounds and combinatorial compound library

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008515985A (ja) * 2004-10-13 2008-05-15 ピーティーシー セラピューティクス，インコーポレーテッド ナンセンス抑制の化合物とその使用方法
US9611230B2 (en) 2004-10-13 2017-04-04 Ptc Therapeutics, Inc. 1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
JP5222561B2 (ja) * 2005-10-07 2013-06-26 キッセイ薬品工業株式会社 含窒素芳香族複素環化合物およびそれを含有する医薬組成物
JPWO2007043400A1 (ja) * 2005-10-07 2009-04-16 キッセイ薬品工業株式会社 含窒素芳香族複素環化合物およびそれを含有する医薬組成物
WO2007043400A1 (ja) * 2005-10-07 2007-04-19 Kissei Pharmaceutical Co., Ltd. 含窒素芳香族複素環化合物およびそれを含有する医薬組成物
US9125410B2 (en) 2007-08-13 2015-09-08 Monsanto Technology Llc Compositions and methods for controlling nematodes
US8435999B2 (en) 2007-08-13 2013-05-07 Monsanto Technology Llc Compositions and methods for controlling nematodes
US9420788B2 (en) 2007-08-13 2016-08-23 Monsanto Technology Llc Compositions and methods for controlling nematodes
US9642364B2 (en) 2007-08-13 2017-05-09 Monsanto Technology Llc Compositions and methods for controlling nematodes
US10112930B2 (en) 2007-08-13 2018-10-30 Monsanto Technology Llc Compositions and methods for controlling nematodes
US10375958B2 (en) 2007-08-13 2019-08-13 Monsanto Technology Llc Compositions and methods for controlling nematodes
US10827753B2 (en) 2007-08-13 2020-11-10 Monsanto Technology Llc Compositions and methods for controlling nematodes
WO2009041072A1 (ja) 2007-09-27 2009-04-02 Kowa Company, Ltd. テトラヒドロキノリン化合物を有効成分とする貧血の予防及び／又は治療剤

Also Published As

Publication number Publication date
AU3276600A (en) 2000-08-25
WO2000046208A1 (de) 2000-08-10
EP1150958A1 (de) 2001-11-07
DE19904406A1 (de) 2000-08-10
CA2361816A1 (en) 2000-08-10
GT200000007A (es) 2001-07-27

Similar Documents

Publication Publication Date Title
US6541474B2 (en) Heterocycle-containing carboxylic acid derivative and drug containing the same
JP4426660B2 (ja) ピラゾール誘導体、その製法および医薬としてのその使用
CN108516958B (zh) 稠环衍生物、其制备方法、中间体、药物组合物及应用
JP2000503014A (ja) 脈管形成阻害性ピリダジンアミン
CN101636397A (zh) 脲类化合物、其制备方法及其医药用途
WO2004048379A1 (ja) キサンチン化合物
JP2002507610A (ja) イミダゾロン食欲抑制薬：ｉｉｉ．ヘテロアリール誘導体
JP2001514227A (ja) ピラジノン系トロンビン阻害薬
EP1513835B1 (de) Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung
JP2002508780A (ja) 新規な化合物
KR20150119942A (ko) Wnt/베타-카테닌 신호전달 경로 활성자로서 감마-디케톤
JP2002518377A (ja) アリールアルカノイルピリダジン
WO2022138888A1 (ja) テトラヒドロキノリン誘導体及びその医薬用途
JP2002507988A (ja) 化合物
EP2310383B1 (de) Derivate von 2-oxoalkyl-1-piperazin-2-on, verfahren zu deren herstellung und deren therapeutische verwendung
JP2002536365A (ja) 貧血と闘うのに使用される置換ピラゾールカルボン酸
JP3162523B2 (ja) ピペリジルメチル−置換クロマン誘導体
JP3853389B2 (ja) 新規の３−フェニルスルホニル−３，７−ジアザビシクロ［３，３，１］ノナン−化合物、その製法及び抗不整脈剤
JPH05186459A (ja) ２−アミノ−５−シアノ−４−キノリン−１，４−ジヒドロピリジン類
CN113980001B (zh) 吡唑醇-哒嗪酮类耦联化合物、其药物组合物及其在药物中的应用
JP2002536348A (ja) ピラゾールカルボキサミドの使用
JP2002512630A (ja) 血管形成抑制チアジアゾリルピリダジン誘導体
JP2002503721A (ja) 置換イソインドロンおよび医薬におけるサイクリックｇｍｐ調節剤としてのそれらの使用
EP1694668B1 (de) 4-[(arylmethyl)aminomethyl]piperidinderivate, deren herstellung und deren anwendung in therapeutika
CN110234631B (zh) 用于治疗高血压和/或纤维化的组合物